Top Articles

I would like to state my deepest gratitude and appreciation to the European Academy of Neurology for having granted me the research-training fellowship for 12 months at Prof. Benazzouz Abdelhamid’s research group, at the Institute of Neurodegenerative disease, Bordeaux University, France.

We congratulate the winners of the EAN Tournament during the 4th EAN Congress in Lisbon.
In two sessions, twelve young scientists presented their outstanding work. The EAN Tournament Prize consists of a certificate, travel, accommodation and registration to the 5th… Continue Reading

Prof. David B. Vodušek (DBV): Kindly illustrate the history, vision and mission of the EANM – European Association of  Nuclear Medicine to the readers of the EAN Pages. Prof. K. Muylle (KM): The European Association of Nuclear Medicine (EANM) is a professional non-profit medical association, incorporated in Vienna/Austria. The EANM’s vision is to optimise and advance science and education in nuclear medicine for the benefit of public health and humanity within the concept of personalised healthcare. The EANM acts as umbrella organisation for individuals as well as national societies.

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

The Guideline will address important areas of dementia management where the medical doctor plays a pivotal role, which includes treatment of epilepsy in dementia, pain in dementia, treatment with antipsychotics in dementia, vascular risk factors in dementia and systematic medical follow-up in dementia.

Prof. Elena Moro (EM): Dear Prof. Hallett, it is a great honor for me, as movement disorders specialist, to ask you few questions on behalf of the EAN members and for all EAN pages readers. In light of your Honorary Membership to the EAN, can you tell us what did make you choose “neurology” as the specialty to pursue? Prof. Mark Hallett (MH): I have been interested in the brain since I took a psychology course in high school.  I pursued neuroscience studies in college, but only decided to go into medicine about half way through college. 

Highlights and late breaking news session 19.06.2018 by Tim von Oertzen This session was chaired by the outgoing EAN president Prof Gunther Deuschl, the chair of the Programme Committee, Prof Paul Boon, the incoming EAN president Franz Fazekas and the… Continue Reading

Meet and greet – 18 June 2018
By Martin Rakusa After the long day at the congress, more than 200 neurologists gathered at the traditional “Meet and greet” event. Among others, the past and the new EAN presidents, the members… Continue Reading

Lisbon 2018: Report on Symposium 6:   Coma: neuromodulation, imaging and neurobiology June 18th, 2018 by Antonella Macerollo This symposium was chaired by Prof Laureys, Belgium, and Dr Diserens, Switzerland. Dr Kondziella from Denmark gave the first presentation titled: Mechanisms of… Continue Reading

Overarching Theme: Molecular and genetic therapies for neurogenetic disorders   18 June 2018   By Tom Jenkins   This plenary session focused on perhaps the most exciting area of clinical neurology in recent years, at least in terms of therapeutic breakthroughs and… Continue Reading

Prof. Günther Deuschl, President of the EAN, also welcomed everybody. He highlighted some recent important studies published by European researchers, the celebration of the Brain Prize in Europe, and some EAN achievements such as the guidelines project. The EAN is also particularly interested in assessing the burden of neurological diseases in Europe.

Recently, EAN held elections of the Scientific Panel Management groups. All Panel Members - institutional that are nominated by a national society, and individual - were invited to send in their applications. The Scientific Committee received altogether 163 applications, from 30 different countries (59 female and 104 male applicants).

The year of 1949 was a celebrating year for Neurosciences in Portugal, since our professor of Neurology Egas Moniz was awarded the Nobel Prize of Medicine and Physiology, an important recognition of his neuroscience research. This was a mark that very much inspired the interest of our medical school on neurosciences.

Scientific plagiarism is defined as using or closely imitating scientific content from an original author without clear reference and/or authorization. Plagiarism can be complete or partial, in the original or translated version or limited to paraphrases of the original text. A textual repetition of one’s own work in subsequent submissions is considered self-plagiarism and should be avoided or at least accompanied by proper referencing to one’s prior work.